Your browser doesn't support javascript.
loading
AD-associated CSF biomolecular changes are attenuated in KL-VS heterozygotes.
Driscoll, Ira; Ma, Yue; Lose, Sarah R; Gallagher, Catherine L; Johnson, Sterling C; Asthana, Sanjay; Hermann, Bruce P; Sager, Mark A; Blennow, Kaj; Zetterberg, Henrik; Carlsson, Cynthia M; Engelman, Corinne D; Dubal, Dena B; Okonkwo, Ozioma C.
Affiliation
  • Driscoll I; Wisconsin Alzheimer's Disease Research Center University of Wisconsin-Madison Madison Wisconsin USA.
  • Ma Y; Wisconsin Alzheimer's Institute Madison Wisconsin USA.
  • Lose SR; Department of Psychology University of Wisconsin-Milwaukee Milwaukee Wisconsin USA.
  • Gallagher CL; Wisconsin Alzheimer's Institute Madison Wisconsin USA.
  • Johnson SC; Wisconsin Alzheimer's Disease Research Center University of Wisconsin-Madison Madison Wisconsin USA.
  • Asthana S; Wisconsin Alzheimer's Institute Madison Wisconsin USA.
  • Hermann BP; Geriatric Research Education and Clinical Center William S. Middleton VA Hospital Madison Wisconsin USA.
  • Sager MA; Department of Neurology University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA.
  • Blennow K; Wisconsin Alzheimer's Disease Research Center University of Wisconsin-Madison Madison Wisconsin USA.
  • Zetterberg H; Wisconsin Alzheimer's Institute Madison Wisconsin USA.
  • Carlsson CM; Geriatric Research Education and Clinical Center William S. Middleton VA Hospital Madison Wisconsin USA.
  • Engelman CD; Wisconsin Alzheimer's Disease Research Center University of Wisconsin-Madison Madison Wisconsin USA.
  • Dubal DB; Wisconsin Alzheimer's Institute Madison Wisconsin USA.
  • Okonkwo OC; Geriatric Research Education and Clinical Center William S. Middleton VA Hospital Madison Wisconsin USA.
Alzheimers Dement (Amst) ; 14(1): e12383, 2022.
Article de En | MEDLINE | ID: mdl-36505396
ABSTRACT

Introduction:

Dementia as an inevitable aging consequence has been challenged and underscores the need for investigations of the factors that confer resilience. We examine whether the functionally advantageous KL-VS variant of the putative aging suppressor KLOTHO gene attenuates age-related cognitive decline and deleterious biomolecular changes.

Methods:

Trajectories of change in memory and executive function (N = 360; 2-12 visits) and cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers-amyloid beta (Aß)42, total tau (t-tau), phosphorylated tau (p-tau) (N = 112; 2-4 samplings)-were compared between KL-VS non-carriers and heterozygotes in middle-aged and older adults from the Wisconsin Registry for Alzheimer's Prevention and the Wisconsin Alzheimer's Disease Research Center studies.

Results:

Memory and executive function declined (p's ≤ 0.001) and CSF t-tau, p-tau, t-tau/Aß42, and p-tau/Aß42 levels increased (all p's ≤ 0.004) with age. The rate of p-tau accumulation was attenuated for KL-VS heterozygotes (p = 0.03).

Discussion:

KL-VS heterozygosity may confer resilience to AD-associated biomolecular changes.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Risk_factors_studies Langue: En Journal: Alzheimers Dement (Amst) Année: 2022 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Risk_factors_studies Langue: En Journal: Alzheimers Dement (Amst) Année: 2022 Type de document: Article
...